JP Patent

JP7839962B2 — Ｂｃｌ－２阻害剤

Assigned to BeOne Medicines I GmbH · Expires 2026-04-03 · 0y expired

What this patent protects

Patent listed against Brukinsa.

Drugs covered by this patent

Brukinsa (ZANUBRUTINIB) · BeiGene

Patent Metadata

Patent number: JP7839962B2
Jurisdiction: JP
Classification: —
Expires: 2026-04-03
Drug substance claim: No
Drug product claim: No
Assignee: BeOne Medicines I GmbH
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.